RSCF
Price
$0.05
Change
-$0.01 (-16.67%)
Updated
Sep 5 closing price
Capitalization
4.69M
RYLPF
Price
$27.72
Change
+$0.37 (+1.35%)
Updated
Sep 4 closing price
Capitalization
26.36B
Interact to see
Advertisement

RSCF vs RYLPF

Header iconRSCF vs RYLPF Comparison
Open Charts RSCF vs RYLPFBanner chart's image
Reflect Scientific
Price$0.05
Change-$0.01 (-16.67%)
Volume$541.37K
Capitalization4.69M
Koninklijke Philips N.V
Price$27.72
Change+$0.37 (+1.35%)
Volume$160
Capitalization26.36B
RSCF vs RYLPF Comparison Chart in %
Loading...
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSCF vs. RYLPF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSCF is a Hold and RYLPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (RSCF: $0.05 vs. RYLPF: $27.72)
Brand notoriety: RSCF and RYLPF are both not notable
RSCF represents the Pharmaceuticals: Other, while RYLPF is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: RSCF: 995% vs. RYLPF: 13%
Market capitalization -- RSCF: $4.69M vs. RYLPF: $26.36B
RSCF [@Pharmaceuticals: Other] is valued at $4.69M. RYLPF’s [@Medical/Nursing Services] market capitalization is $26.36B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSCF’s FA Score shows that 1 FA rating(s) are green whileRYLPF’s FA Score has 1 green FA rating(s).

  • RSCF’s FA Score: 1 green, 4 red.
  • RYLPF’s FA Score: 1 green, 4 red.
According to our system of comparison, RYLPF is a better buy in the long-term than RSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RSCF’s TA Score shows that 4 TA indicator(s) are bullish while RYLPF’s TA Score has 3 bullish TA indicator(s).

  • RSCF’s TA Score: 4 bullish, 5 bearish.
  • RYLPF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, RYLPF is a better buy in the short-term than RSCF.

Price Growth

RSCF (@Pharmaceuticals: Other) experienced а -8.83% price change this week, while RYLPF (@Medical/Nursing Services) price change was +0.77% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYLPF($26.4B) has a higher market cap than RSCF($4.69M). RSCF YTD gains are higher at: 30.238 vs. RYLPF (9.790). RYLPF has higher annual earnings (EBITDA): 2.41B vs. RSCF (8.86K). RYLPF has more cash in the bank: 1.82B vs. RSCF (1.3M). RSCF has less debt than RYLPF: RSCF (141K) vs RYLPF (8.43B). RYLPF has higher revenues than RSCF: RYLPF (17.9B) vs RSCF (1.72M).
RSCFRYLPFRSCF / RYLPF
Capitalization4.69M26.4B0%
EBITDA8.86K2.41B0%
Gain YTD30.2389.790309%
P/E RatioN/A148.60-
Revenue1.72M17.9B0%
Total Cash1.3M1.82B0%
Total Debt141K8.43B0%
FUNDAMENTALS RATINGS
RSCF vs RYLPF: Fundamental Ratings
RSCF
RYLPF
OUTLOOK RATING
1..100
5027
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9291
PRICE GROWTH RATING
1..100
5949
P/E GROWTH RATING
1..100
312
SEASONALITY SCORE
1..100
n/a37

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RYLPF's Valuation (57) in the null industry is in the same range as RSCF (68). This means that RYLPF’s stock grew similarly to RSCF’s over the last 12 months.

RYLPF's Profit vs Risk Rating (100) in the null industry is in the same range as RSCF (100). This means that RYLPF’s stock grew similarly to RSCF’s over the last 12 months.

RYLPF's SMR Rating (91) in the null industry is in the same range as RSCF (92). This means that RYLPF’s stock grew similarly to RSCF’s over the last 12 months.

RYLPF's Price Growth Rating (49) in the null industry is in the same range as RSCF (59). This means that RYLPF’s stock grew similarly to RSCF’s over the last 12 months.

RSCF's P/E Growth Rating (3) in the null industry is in the same range as RYLPF (12). This means that RSCF’s stock grew similarly to RYLPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSCFRYLPF
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 4 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGN10.380.70
+7.23%
Organon & Co
NWSA29.440.14
+0.48%
News Corp
AVNS12.720.06
+0.47%
Avanos Medical
SFBC47.31-0.07
-0.15%
Sound Financial Bancorp
SUGP6.05-0.07
-1.10%
SU Group Holdings Limited

RSCF and

Correlation & Price change

A.I.dvisor tells us that RSCF and MXCT have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCF and MXCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCF
1D Price
Change %
RSCF100%
-8.83%
MXCT - RSCF
22%
Poorly correlated
+3.68%
BRSYF - RSCF
20%
Poorly correlated
N/A
RSMDF - RSCF
10%
Poorly correlated
N/A
RYLPF - RSCF
6%
Poorly correlated
N/A
PFGTF - RSCF
3%
Poorly correlated
N/A
More

RYLPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYLPF has been loosely correlated with MTD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RYLPF jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYLPF
1D Price
Change %
RYLPF100%
N/A
MTD - RYLPF
38%
Loosely correlated
+1.39%
CDNA - RYLPF
28%
Poorly correlated
+5.50%
MBGNF - RYLPF
24%
Poorly correlated
N/A
SRTS - RYLPF
23%
Poorly correlated
+1.57%
WRBY - RYLPF
21%
Poorly correlated
+2.64%
More